• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Severe COVID-19 Is a Microvascular Disease.重症新型冠状病毒肺炎是一种微血管疾病。
Circulation. 2020 Oct 27;142(17):1609-1611. doi: 10.1161/CIRCULATIONAHA.120.050354. Epub 2020 Sep 2.
2
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.Covid-19：纤维蛋白（ogen）、D-二聚体、血管性血友病因子、P-选择素及其与内皮细胞、血小板和红细胞相互作用的过山车。
Int J Mol Sci. 2020 Jul 21;21(14):5168. doi: 10.3390/ijms21145168.
3
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19.高敏心肌肌钙蛋白可成为抗击新冠疫情的有力帮手。
Circulation. 2020 Jun 2;141(22):1733-1735. doi: 10.1161/CIRCULATIONAHA.120.047008. Epub 2020 Apr 6.
4
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.
5
Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure.新型冠状病毒（COVID-19）呼吸衰竭的高压氧治疗
Med Gas Res. 2020 Apr-Jun;10(2):61-62. doi: 10.4103/2045-9912.282177.
6
Coronavirus Disease and Acute Vascular Events.冠状病毒病与急性血管事件
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620929091. doi: 10.1177/1076029620929091.
7
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
8
Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19.在未经过筛选的新冠病毒疾病住院患者中，已确立的心血管生物标志物提供的预后信息有限。
Circulation. 2020 Nov 10;142(19):1878-1880. doi: 10.1161/CIRCULATIONAHA.120.050089. Epub 2020 Sep 10.
9
Productivity of Young Experts in Hemostasis and Thrombosis before and during the SARS-CoV-2 Pandemic-A Special Issue.SARS-CoV-2大流行之前及期间止血与血栓形成领域青年专家的生产力——特刊
Hamostaseologie. 2020 Aug;40(3):255-256. doi: 10.1055/a-1081-6973. Epub 2020 Jul 29.
10
Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan.武汉48例重症新型冠状病毒肺炎患者下肢深静脉血栓形成的极高发生率
Circulation. 2020 Jul 14;142(2):181-183. doi: 10.1161/CIRCULATIONAHA.120.047407. Epub 2020 May 15.

引用本文的文献

1
Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection.磺酰肼作为一种潜在的新型冠状病毒感染抑制剂。
Sci Rep. 2025 May 28;15(1):18732. doi: 10.1038/s41598-025-03685-2.
2
Endothelial ActRIIA inhibition protects the cardiac microvasculature in severe viral respiratory infection.抑制内皮细胞激活素受体IIA可保护严重病毒性呼吸道感染中的心脏微血管。
Res Sq. 2025 Apr 1:rs.3.rs-6306417. doi: 10.21203/rs.3.rs-6306417/v1.
3
Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection.Fgl2在感染过程中调节FcγRIIB+CD8+ T细胞反应。
JCI Insight. 2025 Apr 8;10(7):e186259. doi: 10.1172/jci.insight.186259.
4
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的免疫和炎症后果及其在肾脏疾病中的意义。
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
5
Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence.挑战新冠病毒感染内皮细胞的观念：基于当前科学证据的见解
Front Immunol. 2025 Feb 4;16:1443932. doi: 10.3389/fimmu.2025.1443932. eCollection 2025.
6
Hypercoagulable Rotational Thromboelastometry During Hospital Stay Is Associated with Post-Discharge DLco Impairment in Patients with COVID-19-Related Pneumonia.新冠病毒相关肺炎患者住院期间高凝状态旋转血栓弹力图与出院后弥散功能障碍相关。
Viruses. 2024 Dec 14;16(12):1916. doi: 10.3390/v16121916.
7
Microvascular disease and severe COVID-19 outcomes in UKBiobank participants with diabetes.英国生物银行中患有糖尿病的参与者的微血管疾病与严重新冠病毒病结局
Acta Diabetol. 2025 Mar;62(3):293-301. doi: 10.1007/s00592-024-02420-z. Epub 2024 Nov 21.
8
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary.美国血液学会关于COVID-19患者血栓预防抗凝治疗的实用指南：执行摘要
Blood Adv. 2025 Mar 25;9(6):1247-1260. doi: 10.1182/bloodadvances.2024014219.
9
Anticoagulant use before COVID-19 diagnosis prevent COVID-19 associated acute venous thromboembolism or not: A systematic review and meta-analysis.新冠病毒病诊断前使用抗凝剂能否预防新冠病毒病相关急性静脉血栓栓塞：一项系统评价与荟萃分析
World J Methodol. 2024 Sep 20;14(3):92983. doi: 10.5662/wjm.v14.i3.92983.
10
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成：区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.

本文引用的文献

1
Endothelial cells orchestrate COVID-19 coagulopathy.内皮细胞在新型冠状病毒肺炎凝血病中起关键作用。
Lancet Haematol. 2020 Aug;7(8):e553-e555. doi: 10.1016/S2352-3026(20)30215-5. Epub 2020 Jun 30.
2
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.新型冠状病毒肺炎相关凝血病中的内皮病变：来自一项单中心横断面研究的证据
Lancet Haematol. 2020 Aug;7(8):e575-e582. doi: 10.1016/S2352-3026(20)30216-7. Epub 2020 Jun 30.
3
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
4
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
Severe COVID-19 infection associated with endothelial activation.严重的2019冠状病毒病感染与内皮细胞激活有关。
Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.

Severe COVID-19 Is a Microvascular Disease.

作者信息

Lowenstein Charles J, Solomon Scott D

机构信息

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (C.J.L.).

出版信息

Circulation. 2020 Oct 27;142(17):1609-1611. doi: 10.1161/CIRCULATIONAHA.120.050354. Epub 2020 Sep 2.

DOI:10.1161/CIRCULATIONAHA.120.050354
PMID:32877231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7580651/
Abstract
摘要